BioNuteral Announces It's Promoting Product at Several Top Trade Shows
May 01 2014 - 7:00AM
Marketwired
BioNuteral Announces It's Promoting Product at Several Top Trade
Shows
NEWARK, NJ--(Marketwired - May 1, 2014) - BioNeutral Group, Inc.
(OTCBB: BONU) (OTCQB: BONU), today announced that Quip Laboratories
(Quip) is continuing to make progress in its commercialization
process of the BioNeutral products for the market segments of
laboratory animal research and biomedical research.
Quip Laboratories a leader in sales distribution of cleaning and
disinfection solutions to the life science marketplace since 1981
is process of completing the third major element of its 2014
commercialization strategy of the BioNeutral products. First,
YGIENE™ 206 and OGIENE™ Odor Eliminator product training was
completed during the annual "QUIP University" Sales meeting in
March. Second, QUIP has featured YGIENE™ 206 in its recent market
awareness campaign of April 4th, April 17thand April 23rd, 2014 and
third, YGIENE™ 206 and OGIENE™ OE are scheduled to be introduced at
a number of The Life Sciences market trade shows beginning this
spring.
A very important element to QUIP's commercialization strategy of
the BioNeutral products is the impressive list of Life Sciences
trade shows where they will be introducing both YGIENE 206 and
OGIENE™ Odor eliminator. The Regional and National Trade Shows will
play a major role in establishing both YGIENE™ and OGIENE™ as core
products in the impressive portfolio of the highly respected QUIP
product offerings. See trade show schedule below:
April 9-11, 2014 - LAMA/ATA Annual Meeting, Scottsdale, AZ April
17-18, 2014 - 2014 District 8 Meeting, South San Francisco, CA
April 30, 2014 - Mile High Branch Spring 2014 AALAS Meeting, Fort
Collins, CO May 1-2, 2014 - QUAD Symposium, Uncasville, CT May
13-14, 2014 - The Turn-Key Conference, National Harbor, MD May
14-16, 2014 - 2014 District 5 AALAS Annual Meeting, Lexington, KY
September 19-20, 2014 - CVMA, Loveland, CA October 8-12, 2014 -
Wild West Vet Conference, Reno, NV October 19-23, 2014 - 2014 AALAS
Nationals, San Antonio, TX
These three elements of QUIP's commercialization strategy will
be very important to the success of both YGIENE™ and OGIENE™ to
this important market segment for BioNeutral.
"It is great to see QUIP Laboratories aggressively attack the
Life Sciences Marketplace with multiple strategies" commented Ray
Dunning, Sr. Vice President of Sales for BioNeutral, "with their
Sales Team fully trained, the market awareness campaign in full
swing and the BioNeutral products being introduced at these well
attended trade shows, the Lab Animal Research and Biotech customers
will have full access to our exciting new facility hygiene
technologies that will become an important weapon to prevent
infections."
About Quip Laboratories, Inc.
Based in Wilmington, DE and founded in 1981, Quip Laboratories
focuses on providing sanitation solutions to Life Science and Food
Processing sectors. Their state-of-the-art manufacturing facility
produces proprietary chemicals that have enabled the company to
achieve a leadership position in the markets served. Featuring
in-house research and development, production, quality control and
sales and marketing, Quip provides a "total-systems" approach to
providing efficient and eco-gentle environment hygiene. Find Quip
at www.quiplabs.com.
About BioNeutral Group, Inc.
Headquartered in Newark, New Jersey, BioNeutral Group, Inc., is
a specialty technology-based life-science company that has
developed a technology platform that neutralizes harmful
environmental contaminants, toxins and dangerous micro-organisms
including bacteria, viruses, mold, fungi and spores. BioNeutral's
products, YGIENE™ and OGIENE™, kill germs and clean surfaces with a
dramatic increase in speed and power over their rivals in the
marketplace. BioNeutral's proprietary platform technology has been
proven effective in surface, water and airborne applications. For
more information on BioNeutral, including a listing of company
products, leadership and background please visit
www.bioneutral.com.
Find us on Facebook:
http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
Forward-Looking Statements: This release contains
certain "forward-looking statements" relating to the business of
the Company and its subsidiary companies. These forward-looking
statements are often identified by the use of forward-looking
terminology such as "believes," "expects" or similar expressions.
Such forward-looking statements involve known and unknown risks and
uncertainties that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company's actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those
described in the Company's filings with the Securities and Exchange
Commission. BioNeutral routinely tests its formulations against
those of its competitors. The results are published to let
shareholders know how the Company's technology compares with known
formulations in the market place. Any product claim for
antimicrobial activity requires approval from the EPA or FDA,
depending upon where and how the formulations are used. The EPA has
approved and registered the Company's data and findings specific to
Ygiene-206. BioNeutral's antimicrobial formulations will be
marketed under the brand name Ygiene® and are available for sale in
the United States.
CONTACT: FOR THE COMPANY: Mark Lowenthal CEO BioNeutral Group,
Inc. +1-973-577-8003